Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06817668 · ClinicalTrials.gov registry record · NA

Evaluating Tolerability of ePUHRT With Brachytherapy Boost

A NA study of Prostate Cancer, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT06817668: Recruiting NA study of Prostate Cancer, sponsored by Indiana University.

NCT06817668 is a NA study of Prostate Cancer that is actively recruiting participants, run by Indiana University. The registered enrollment target is 31 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06817668, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the tolerability and toxicity of combining two radiation therapy methods for prostate cancer: Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT), which is an external beam radiotherapy with High Dose Rate Brachytherapy Boost (form of internal radiation where a cancer doctor implants a small plastic tube or balloon (catheter) in the tumor).

Conditions Studied

Prostate Cancer

Interventions

  • RADIATION ePURT 5Gy x 5 fractions with single HDR boost of 15Gy

Study Locations (1)

Indiana

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center - Indianapolis

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2025-03-05
Est. Completion 2028-10
Phase NA

Sponsor

Indiana University

890 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06817668

The ClinicalTrials.gov registry entry for NCT06817668 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which ePURT 5Gy x 5 fractions with single HDR boost of 15Gy is the first listed.

NCT06817668 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT06817668 about?

NCT06817668 is a clinical study titled "Evaluating Tolerability of ePUHRT With Brachytherapy Boost". The purpose of this study is to evaluate the tolerability and toxicity of combining two radiation therapy methods for prostate cancer: Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT), which is an external beam radiotherapy with High Dose Rate Brachytherapy Boost (form of intern...

What is the current status of trial NCT06817668?

This trial is currently recruiting. It is a NA study. The enrollment target is 31 participants. The study started on 2025-03-05. Estimated completion is 2028-10.

What conditions does trial NCT06817668 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT06817668?

The interventions under investigation include: ePURT 5Gy x 5 fractions with single HDR boost of 15Gy (RADIATION).

Who is sponsoring clinical trial NCT06817668?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06817668 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Indiana

All trials with a study site in Indiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.